94.5% Efficiency: Moderna Announces Successful Vaccine Trials




The American company Moderna said its vaccine was 94.5% effective during the third phase of trials.





This is stated in a press release from the company.

More than 30,000 people in the United States are reportedly involved in the study. It is being conducted in collaboration with the National Institutes of Health and the US Department of Health and Human Services.

Earlier it was reported that Moderna intends to set a price for its coronavirus vaccine at $ 50-60 per vaccination course, which is about $ 25-30 per dose.

Recall that the American pharmaceutical company Pfizer has already sold the majority of its vaccine against coronavirus infection, the effectiveness of which is estimated at 90%.


Google News
Views: 108

TAGS: VACCINE, CORONAVIRUS

Add a comment!

Your name:
Your Email:
  • bowtiesmilelaughingblushsmileyrelaxedsmirk
    heart_eyeskissing_heartkissing_closed_eyesflushedrelievedsatisfiedgrin
    winkstuck_out_tongue_winking_eyestuck_out_tongue_closed_eyesgrinningkissingstuck_out_tonguesleeping
    worriedfrowninganguishedopen_mouthgrimacingconfusedhushed
    expressionlessunamusedsweat_smilesweatdisappointed_relievedwearypensive
    disappointedconfoundedfearfulcold_sweatperseverecrysob
    joyastonishedscreamtired_faceangryragetriumph
    sleepyyummasksunglassesdizzy_faceimpsmiling_imp
    neutral_faceno_mouthinnocent
The code:
Кликните на изображение чтобы обновить код, если он неразборчив
Enter a code: